Loading
No insider purchase over the last 90 days. The latest, by JOHN N KAPOOR TRUST DATED SEPTEMBER 20 1989, was filed 14 Aug 2017.
Insys Therapeutics, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). No insider at Insys Therapeutics, Inc. has published a filing in the past twelve months. The most recent one dates from 6 June 2019.
Over the whole record (from 2016), the tally stands at 10 purchases and 7 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
25 of 80 declarations
Insys Therapeutics, Inc. is a pharmaceutical company focused on developing treatments, particularly for pain management. It is listed on the NASDAQ under the ticker symbol INSY.